Disruption of striatal glutamatergic/GABAergic homeostasis following acute methamphetamine in mice

Neurotoxicology and Teratology

Volumn 34, Issue 5, 2012, Pages 522-529

  Pereira, Frederico C ^a   Cunha Oliveira, Teresa ^b   Viana, Sofia D ^a   Travassos, Ana S ^a   Nunes, Sara ^a   Silva, Carlos ^a   Prediger, Rui Daniel ^c   Rego, A Cristina ^a,b   Ali, Syed F ^d   Ribeiro, Carlos Alberto Fontes ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^d NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Glutamate GABA homeostasis; Locomotion; Methamphetamine; RAGE; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLEACETIC ACID; ADVANCED GLYCATION END PRODUCT RECEPTOR; DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINE; METHAMPHETAMINE; SEROTONIN; TYROSINE 3 MONOOXYGENASE;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; GABAERGIC SYSTEM; LOCOMOTION; MALE; MOTOR ACTIVITY; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL;

ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCOSYLATION END PRODUCTS, ADVANCED; HOMEOSTASIS; HYDROXYINDOLEACETIC ACID; INJECTIONS, INTRAPERITONEAL; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; SEROTONIN;

MUS; RODENTIA;

EID: 84865986530     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2012.07.005     Document Type: Article

References (46)

1. Ali S.F., Newport G.D., Holson R.R., Slikker W., Bowyer J.F. Low environmental temperatures or pharmacologic agents that produce hypothermia decrease methamphetamine neurotoxicity in mice. Brain Res 1994, 658:33-38.
2. Arbuthnott G.W., Wickens J. Space, time and dopamine. Trends Neurosci 2007, 30:62-69.
3. Bak L.K., Schousboe A., Waagepetersen H.S. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 2006, 98:641-653.
4. Benjamin A.M., Quastel J.H. Fate of l-glutamate in the brain. J Neurochem 1974, 23:457-464.
5. Broer S., Brookes N. Transfer of glutamine between astrocytes and neurons. J Neurochem 2001, 77:705-719.
6. Bustamante D., You Z.B., Castel M.N., Johansson S., Goiny M., Terenius L., et al. Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat. J Neurochem 2002, 83:645-654.
7. Cammer W., Downing M. Localization of the multifunctional protein CAD in astrocytes of rodent brain. J Histochem Cytochem 1991, 39:695-700.
8. Ding Q., Keller J.N. Evaluation of rage isoforms, ligands, and signaling in the brain. Biochim Biophys Acta 2005, 1746:18-27.
9. Ernst T., Chang L. Adaptation of brain glutamate plus glutamine during abstinence from chronic methamphetamine use. J Neuroimmune Pharmacol 2008, 3:165-172.
10. Fumagalli F., Gainetdinov R.R., Valenzano K.J., Caron M.G. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J Neurosci 1998, 18:4861-4869.
11. Grace C.E., Schaefer T.L., Herring N.R., Graham D.L., Skelton M.R., Gudelsky G.A., et al. Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL/6 mice. Neurotoxicol Teratol 2010, 32:346-355.
12. Haughey H.M., Brown J.M., Wilkins D.G., Hanson G.R., Fleckenstein A.E. Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transporters. Brain Res 2000, 863:59-65.
13. Hertz L., Dringen R., Schousboe A., Robinson S.R. Astrocytes: glutamate producers for neurons. J Neurosci Res 1999, 57:417-428.
14. Jayanthi S., Deng X., Noailles P.A., Ladenheim B., Cadet J.L. Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J 2004, 18:238-251.
15. Krasnova I.N., Cadet J.L. Methamphetamine toxicity and messengers of death. Brain Res Rev 2009, 60:379-407.
16. Li Y., Blanco G.D., Lei Z., Xu Z.C. Increased GAD expression in the striatum after transient cerebral ischemia. Mol Cell Neurosci 2010, 45:370-377.
17. Mark K.A., Soghomonian J.J., Yamamoto B.K. High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J Neurosci 2004, 24:11449-11456.
18. Miller D.B., O'Callaghan J.P., Ali S.F. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure. Ann N Y Acad Sci 2000, 914:194-207.
19. Muscoli C., Visalli V., Colica C., Nistico R., Palma E., Costa N., et al. The effect of inflammatory stimuli on NMDA-related activation of glutamine synthase in human cultured astroglial cells. Neurosci Lett 2005, 373:184-188.
20. O'Callaghan J.P., Miller D.B. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 1994, 270:741-751.
21. O'Callaghan J.P., Sriram K., Miller D.B. Defining "neuroinflammation". Ann N Y Acad Sci 2008, 1139:318-330.
22. Patel A.B., Rothman D.L., Cline G.W., Behar K.L. Glutamine is the major precursor for GABA synthesis in rat neocortex in vivo following acute GABA-transaminase inhibition. Brain Res 2001, 919:207-220.
23. Pekny M., Johansson C.B., Eliasson C., Stakeberg J., Wallen A., Perlmann T., et al. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 1999, 145:503-514.
24. Pereira F.C., Lourenco E.S., Borges F., Morgadinho T., Ribeiro C.F., Macedo T.R., et al. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen. Synapse 2006, 60:185-193.
25. Pubill D., Canudas A.M., Pallas M., Camins A., Camarasa J., Escubedo E. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity. Naunyn Schmiedebergs Arch Pharmacol 2003, 367:490-499.
26. Rae C., Hare N., Bubb W.A., McEwan S.R., Broer A., McQuillan J.A., et al. Inhibition of glutamine transport depletes glutamate and GABA neurotransmitter pools: further evidence for metabolic compartmentation. J Neurochem 2003, 85:503-514.
27. Rego A.C., Santos M.S., Oliveira C.R. Oxidative stress, hypoxia, and ischemia-like conditions increase the release of endogenous amino acids by distinct mechanisms in cultured retinal cells. J Neurochem 1996, 66:2506-2516.
28. Sailasuta N., Abulseoud O., Harris K.C., Ross B.D. Glial dysfunction in abstinent methamphetamine abusers. J Cereb Blood Flow Metab 2010, 30:950-960.
29. Sekine Y., Ouchi Y., Takei N., Yoshikawa E., Nakamura K., Futatsubashi M., et al. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Arch Gen Psychiatry 2006, 63:90-100.
30. Shen H., Luo Y., Yu S.J., Wang Y. Enhanced neurodegeneration after a high dose of methamphetamine in adenosine A3 receptor null mutant mice. Neuroscience 2011, 194:170-180.
31. Simoes P.F., Silva A.P., Pereira F.C., Marques E., Milhazes N., Borges F., et al. Methamphetamine changes NMDA and AMPA glutamate receptor subunit levels in the rat striatum and frontal cortex. Ann N Y Acad Sci 2008, 1139:232-241.
32. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85.
33. Tisch S., Silberstein P., Limousin-Dowsey P., Jahanshahi M. The basal ganglia: anatomy, physiology, and pharmacology. Psychiatr Clin North Am 2004, 27:757-799.
34. Toomey R., Lyons M.J., Eisen S.A., Xian H., Chantarujikapong S., Seidman L.J., et al. A twin study of the neuropsychological consequences of stimulant abuse. Arch Gen Psychiatry 2003, 60:303-310.
35. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Leonido-Yee M., Franceschi D., et al. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers. Am J Psychiatry 2001, 158:377-382.
36. Waagepetersen H.S., Sonnewald U., Schousboe A. Compartmentation of glutamine, glutamate, and GABA metabolism in neurons and astrocytes: functional implications. Neuroscientist 2003, 9:398-403.
37. Wang L., Maher T.J., Wurtman R.J. Oral l-glutamine increases GABA levels in striatal tissue and extracellular fluid. FASEB J 2007, 21:1227-1232.
38. Wilson C.J. GABAergic inhibition in the neostriatum. Prog Brain Res 2007, 160:91-110.
39. Wilson J.M., Kalasinsky K.S., Levey A.I., Bergeron C., Reiber G., Anthony R.M., et al. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nat Med 1996, 2:699-703.
40. Xu W., Zhu J.P., Angulo J.A. Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors. Synapse 2005, 58:110-121.
41. Yamamoto B.K., Raudensky J. The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. J Neuroimmune Pharmacol 2008, 3:203-217.
42. Yamamoto B.K., Moszczynska A., Gudelsky G.A. Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci 2010, 1187:101-121.
43. Zhang X., Lee T.H., Xiong X., Chen Q., Davidson C., Wetsel W.C., et al. Methamphetamine induces long-term changes in GABAA receptor alpha2 subunit and GAD67 expression. Biochem Biophys Res Commun 2006, 351:300-305.
44. Zhu J.P., Xu W., Angulo J.A. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice. Brain Res 2005, 1049:171-181.
45. Zhu J.P., Xu W., Angulo J.A. Methamphetamine-induced cell death: selective vulnerability in neuronal subpopulations of the striatum in mice. Neuroscience 2006, 140:607-622.
46. Zhu J.P., Xu W., Angulo N., Angulo J.A. Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration. Neurotoxicology 2006, 27:131-136.